VC  Agent Capital

https://www.agentcapital.com





     Office Locations:

810 Memorial Drive, Mezzanine Floor, Suite 107
Cambridge, MA 02139
Phone: 844-691-6233

 

Stages:

  • Early
  • Expansion
  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Agent Capital is a biotech venture capital firm focused on investing in novel therapeutics that address unmet patient need. The firm maintains a balanced two-pronged approach, between clinical stage companies with high commercial potential and early-stage transformative technologies prime for future M&A. The firm makes direct equity investments across all stages of clinical development in Therapeutic Areas such as: Rare diseases, Oncology, Neurology / CNS, and Immunology.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Geeta Vermuri Managing Partner
    Marta New Partner
    Preston Noon Principal

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/18/2017


      Aptinyx


      IL


      $70,000,000


      Series B


     

    Portfolio companies include:


      Aptinyx
        web link


      Orbus Therapeutics


      Orchard Therapeutics


      Palvella Therapeutics


      Verge Genomics


     

    Recent News: